Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-10 1:37 pm Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | EcoR1 Capital LLC | 6,184,861 7.4% | 808,727 (+15.04%) | View |
2023-02-10 1:13 pm Sale | 13G | ALECTOR INC ALEC | EcoR1 Capital LLC | 4,056,548 4.9% | -938,422 (-18.79%) | View |
2023-02-09 5:55 pm Sale | 13G | SOLID BIOSCIENCES INC SLDB | EcoR1 Capital LLC | 0 0% | -9,202,702 (Position Closed) | View |
2023-02-09 5:47 pm Sale | 13G | REATA PHARMACEUTICALS INC RETA | EcoR1 Capital LLC | 0 0% | -1,975,611 (Position Closed) | View |
2023-02-09 5:42 pm Sale | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital LLC | 0 0% | -5,523,358 (Position Closed) | View |
2023-01-23 12:14 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | EcoR1 Capital LLC | 4,478,050 5% | 199,981 (+4.67%) | View |
2023-01-20 5:32 pm Purchase | 13G | JANUX THERAPEUTICS INC JANX | EcoR1 Capital LLC | 3,255,270 7.8% | 3,255,270 (New Position) | View |
2023-01-13 4:33 pm Sale | 13G | VOYAGER THERAPEUTICS INC VYGR | EcoR1 Capital LLC | 3,851,507 9.98% | -425,000 (-9.94%) | View |
2023-01-09 4:26 pm Purchase | 13G | GRAPHITE BIO INC GRPH | EcoR1 Capital LLC | 8,538,446 14.7% | 2,826,350 (+49.48%) | View |
2022-12-22 6:07 pm Purchase | 13G | ADICET BIO INC ACET | EcoR1 Capital LLC | 3,560,700 8.3% | 3,560,700 (New Position) | View |
2022-11-23 12:28 pm Purchase | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | EcoR1 Capital LLC | 5,232,279 5.5% | 5,232,279 (New Position) | View |
2022-11-18 1:40 pm Purchase | 13G | GRAPHITE BIO INC GRPH | EcoR1 Capital LLC | 5,712,096 9.8% | 5,712,096 (New Position) | View |
2022-11-14 4:56 pm Purchase | 13G | ABEONA THERAPEUTICS INC NE ABEO | EcoR1 Capital LLC | 1,785,663 9.99% | 1,785,663 (New Position) | View |
2022-11-01 4:01 pm Purchase | 13G | ZYMEWORKS INC ZYME | EcoR1 Capital LLC | 7,568,573 12% | 1,600,000 (+26.81%) | View |
2022-10-28 5:34 pm Purchase | 13G | NGM BIOPHARMACEUTICALS INC NGM | EcoR1 Capital LLC | 6,435,518 8% | 6,435,518 (New Position) | View |
2022-10-28 5:33 pm Purchase | 13G | ZYMEWORKS INC ZYME | EcoR1 Capital LLC | 5,968,573 9.9% | 5,968,573 (New Position) | View |
2022-09-26 4:06 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | EcoR1 Capital LLC | 3,493,194 5.5% | 3,493,194 (New Position) | View |
2022-09-19 08:27 am Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | EcoR1 Capital LLC | 3,460,208 5.5% | 3,460,208 (New Position) | View |
2022-06-27 4:33 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | EcoR1 Capital LLC | 4,278,069 5.8% | 4,278,069 (New Position) | View |
2022-05-16 4:08 pm Purchase | 13G | ARVINAS INC ARVN | EcoR1 Capital LLC | 3,123,300 5.9% | 3,123,300 (New Position) | View |